Hst was Idex’s largest segment in fiscal 2025, bringing in $1.50B of $3.46B (43%).
| Business Segments | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fmt | $1.17B | $1.25B | $1.23B | $1.22B | |||||||||||||
| Fluid & Metering Technologies | — | — | — | — | |||||||||||||
| Hst | $1.34B | $1.32B | $1.30B | $1.50B | |||||||||||||
| Health & Science Technologies | — | — | — | — | |||||||||||||
| Fsdp | $679.20M | $718.80M | $744.30M | $745.30M | |||||||||||||
| Fire & Safety/ Diversified Products | — | — | — | — | |||||||||||||
| Fire & Safety/Diversified Products | — | — | — | — | |||||||||||||
| Fire & Safety & Diversified Products | — | — | — | — | |||||||||||||
| Dispensing Equipment | — | — | — | — | |||||||||||||
| Intersegment Elimination | -$3.80M | -$8.40M | -$6.80M | -$7.30M | |||||||||||||
| Intersegment Eliminations | — | — | — | — | |||||||||||||
| Total | $3.18B | $3.27B | $3.27B | $3.46B |
Idex brought in $3.46B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 5.8% from $3.27B in fiscal 2024. Hst was the largest at $1.50B (43.3%), ahead of Fmt at $1.22B (35.4%) and Fsdp at $745.30M (21.6%).
Compared with fiscal 2024, Hst grew fastest, up 15.2% to $1.50B, while Fmt fell the most, down 0.7% to $1.22B. From fiscal 2022 to 2025, combined revenue from these segments grew from $3.18B to $3.46B, a compound annual growth rate of 2.8%. Hst's share of the total rose from 42.1% to 43.3%.
The total is net of Intersegment Elimination, which took $7.30M off revenue in fiscal 2025.
U.S. Plans was Idex’s largest region in fiscal 2015, bringing in $1.02B of $2.02B (50%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 |
|---|---|---|---|---|---|---|---|
| U.S. Plans | — | — | — | $1.02B | |||
| U.S | $963.14M | $983.79M | $1.07B | — | |||
| Europe | $479.74M | $521.49M | $527.98M | $490.44M | |||
| Asia | $305.19M | $306.47M | $337.67M | $325.51M | |||
| Other Countries | $113.18M | $124.17M | $117.45M | $103.60M | |||
| North America, Excluding U.S | — | — | $95.92M | $85.85M | |||
| North America, Excluding United States | $93.01M | $88.21M | — | — | |||
| Total | $1.95B | $2.02B | $2.15B | $2.02B |
Idex brought in $2.02B from its five regions in fiscal 2015, the year ended December 31, 2015. Idex regrouped these regions after fiscal 2014, so the total does not compare directly with that year's $2.15B. U.S. Plans was the largest at $1.02B (50.2%), ahead of Europe at $490.44M (24.3%) and Asia at $325.51M (16.1%). The other two regions brought in $189.45M combined.
Compared with fiscal 2014, every region above 2% of revenue shrank. Asia held up best, down 3.6% to $325.51M, and Other Countries fell the most, down 11.8% to $103.60M.
Idex began breaking out U.S. Plans in fiscal 2015 and North America, Excluding U.S in fiscal 2014. Idex stopped reporting U.S ($1.07B in fiscal 2014) and North America, Excluding United States ($88.21M in fiscal 2013) as separate regions.
Idex (IEX) reports its revenue by business segments and by geography. In fiscal 2025, Hst was its largest segment, bringing in $1.50B (43.3% of the total), followed by Fmt at $1.22B (35.4%).
Hst was Idex's largest segment in fiscal 2025, bringing in $1.50B, or 43.3% of the $3.46B total across its four segments.
U.S. Plans was Idex's largest region in fiscal 2015, bringing in $1.02B, or 50.2% of the $2.02B total across its five regions.
Among Idex's segments that make up at least 2% of revenue, Hst grew fastest in fiscal 2025, up 15.2% from $1.30B to $1.50B.
Every figure comes from Idex's annual financial filings, as reported. Each line keeps the name Idex gives it, and years follow its fiscal calendar.
Idex's revenue by business segments goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.